There was no difference in major cardiovascular events when statin initiation was based on coronary artery calcium compared ...
CHICAGO, July 08, 2025--(BUSINESS WIRE)--Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO), a precision cardiovascular medicine company with a pioneering technology at the intersection of epigenetics ...
Background: Epigenetic clocks derived from DNA methylation estimate biological aging and have been associated with ...
On Average, 41% More Sensitive Than Current Tests for Predicting Future Heart Disease in Women CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease ...
SAN FRANCISCO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- A new study is the first to show that a remote cognitive assessment could help with tracking patients with cardiovascular risk. The assessments ...
Elucid Raises $55M to expand its AI cardiovascular platform and accelerate commercialisation of personalised diagnostic tools ...
Cardiovascular diseases cause nearly 25% of deaths in India, often ignoring menstrual health Hormonal changes in menstrual cycle affect heart rate, blood pressure, and vascular function Menstrual ...
The 10-year risk estimates for major adverse cardiovascular events underestimate the 20-year cardiovascular burden by nearly three- to tenfold, with the increase in events between 10 and 20 years ...
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease prevention and early detection more accessible, personalized and precise, announces the launch ...
Cardiovascular diseases account for nearly 25% of all deaths in India, yet women's menstrual health is rarely considered during routine cardiovascular assessments. Fluctuations in oestrogen and ...